Drug Discovery

 

Drug Discovery, Wednesday 24 April 2024

last published: 25/Apr/24 19:55
BOOK NOW

Drug Discovery, Thursday 25 April 2024

Pete Thornton
Drug Discovery
11:59

Chair's Remarks

Pete Thornton, VP, Pharma Services & Strategic Partnerships, Invitae
Panel discussion
Drug Discovery
12:00

CureAP-4 drug discovery for ultra-rare CNS disease

Kasey Edwards, Co-Founder, Community Relations Specialist, Cure AP-4
Lauren Dougherty, Chief Operating Officer, TREND Community
Panel discussion
Drug Discovery
12:20

Leveraging at-scale genetic testing data to accelerate precision drug discovery for rare diseases

Sun-Gou Ji, Vice President of Computational Genetics, BridgeBio Pharma
Alix Lacoste, AI Computational Biology Director Genetic Insights, Invitae
Julia Taravella
Drug Discovery
12:40

In-house drug development for patient advocacy groups

Julia Taravella, Exececutive Director, Rare Trait Hope Fund
Panel discussion
Drug Discovery
13:00

Interactive Discussion: A new data frontier: Harnessing AI to unlock rare disease insights from social media conversations

Colton Flowers, NLP Engineer, TREND Community
Max Flurie, Senior Data Scientist, TREND Community
Pete Thornton
Drug Discovery
15:14

Chair's Remarks

Pete Thornton, VP, Pharma Services & Strategic Partnerships, Invitae
Panel discussion
Drug Discovery
15:15

Accelerate and advance drug development: From Patients to approvals

Priya S Chockalingam, Vice President, Head of Clinical Bioanalytics & Translational Sciences, Beam Therapeutics
Sarah Gheuens, Chief Medical Officer, Head of R&D, Agios Pharmaceuticals
Panel discussion
Drug Discovery
15:35

How caregiver and patient driven medical discoveries impact rare diseases

Patricia Weltin, Chief Executive Officer, Beyond the Diagnosis
Annette Maughan, CEO/Co-Founder, KBG Foundation
Panel discussion
Drug Discovery
15:55

Drug discovery for treating rare disease patients

Moderator: Justin Yang, Co-Founder, Kaibab Health & DMV Bio
Sarah Gheuens, Chief Medical Officer, Head of R&D, Agios Pharmaceuticals
Tricha Shivas, Chief Strategy Officer, Foundation for Sarcoidosis Research
Cathleen Lutz, Vice President of the Rare Disease Translational Center, Jackson Laboratory
last published: 25/Apr/24 19:55
BOOK NOW

 

Get Involved At World Orphan Drug Congress USA

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Gina McHugh
gina.mchugh@terrapinn.com
t/ +1 646 619 1775

 

 

 

Marketing & Press Opportunities

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com